Predicting the Occurrence of Cachexia in Patients with BCLC Stage B/C Hepatocellular Carcinoma Receiving Systemic Therapy: A Nomogram Based on Common Clinical Parameters
Weihong Ma, Jie Han, Hongli Yu, Zhipeng Liang, Caiyun Peng, Yinying Lu · 2025
Read Predicting the Occurrence of Cachexia in Patients with BCLC Stage B/C Hepatocellular Carcinoma Receiving Systemic Therapy: A Nomogram Based on Common Clinical Parameters by Weihong Ma, Jie Han, Hongli Yu, Zhipeng Liang, Caiyun Peng, Yinying Lu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732188.txt.
Description
Weihong Ma and co-authors build a chart to predict wasting syndrome in liver cancer patients on drug therapy. About half of patients with mid or late stage liver cancer develop cachexia, a deep loss of weight and muscle. Spotting risk early lets teams feed and support patients before the slide.
The study follows nine hundred six patients at one Beijing hospital across four years. Records before treatment supply common clinical and blood values. The team winnows traits with stepwise tests until a firm set remains. Age, the largest liver lesion size, spread beyond the liver, a blood inflammation ratio, and bile acid levels made the final chart. Checks show the nomogram sorts future cases well. Clinics can run it from routine data, with no exotic tests required.
Catalog record
| CREATOR | Weihong Ma, Jie Han, Hongli Yu, Zhipeng Liang, Caiyun Peng, Yinying Lu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |